SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.33 revenue of $3.3M
- Sonoma Pharmaceuticals press release ( NASDAQ: SNOA ): Q2 GAAP EPS of -$0.33.
- Revenue of $3.3M (-11.8% Y/Y).
- EBITDAS loss for the quarter ended September 30, 2022 of $0.6M decreased $0.3M, compared to an EBITDAS loss of $0.9M for the same period last year.
For further details see:
Sonoma Pharmaceuticals GAAP EPS of -$0.33, revenue of $3.3M